Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00495560 · ClinicalTrials.gov registry record · NA
A Pilot Study of Priming Before Induction Termination of Pregnancy
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00495560 is a NA study that has completed, run by Boston University. The registered enrollment target is 25 participants.
The verdict
NCT00495560, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Induction termination of pregnancy (second trimester abortion) has a median time of 14 hours from the start of medication (misoprostol) to expulsion of the fetus. The objective of this study is to evaluate a method of 'priming' on the length of induction termination of pregnancy. "Priming" refers to the use of medication to ready the cervix and uterus so that the uterus is more sensitive to medication and contracts more effectively, and also refers to softening of the cervix so that there is less resistance to dilation. Priming is used extensively before induction of labor for term pregnancy and is also used extensively before surgical abortion in second trimester. We would like to add priming the evening before induction to the usual treatment and evaluate whether the length of the induction process is shortened. Women are admitted to the hospital in the morning to start misoprostol medication, and unless expulsion occurs within 8-10 hours, need to stay overnight. The study design is to give the priming dose 12 hours before admission. The outcome of interest is the induction time from the first dose on misoprostol in the hospital to expulsion of the fetus. This study aims to assess whether the use of misoprostol as a priming agent would be beneficial with women who undergo induction termination of pregnancy.
Interventions
- DRUG Addition of misoprostol 25 mcg 12 hours before induction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-01 |
| Est. Completion | 2007-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00495560
The ClinicalTrials.gov registry entry for NCT00495560 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Addition of misoprostol 25 mcg 12 hours before induction is the first listed.
NCT00495560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00495560 about?
NCT00495560 is a clinical study titled "A Pilot Study of Priming Before Induction Termination of Pregnancy". Induction termination of pregnancy (second trimester abortion) has a median time of 14 hours from the start of medication (misoprostol) to expulsion of the fetus. The objective of this study is to evaluate a method of 'priming' on the length of induction termination of pregnancy. "Priming" refers to...
What is the current status of trial NCT00495560?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2007-01. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00495560?
The interventions under investigation include: Addition of misoprostol 25 mcg 12 hours before induction (DRUG).
Who is sponsoring clinical trial NCT00495560?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.